Ajanta Pharma Share Price
3563.60+63.10 (+1.80%)
+40.05% past 1 Year
Corporate filings & documents
Announcements
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 18 2026 for Aayush Agrawal trustee Aayush Agrawal Trust
2 days agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 18 2026 for Aayush Agrawal trustee Aayush Agrawal Trust
2 days agoPls find enclosed Intimation w.r.t Participation in Investor Conference.
2 weeks agoPls find enclosed Intimation w.r.t Participation in Investor Conference.
2 weeks agoPls find enclosed newspaper publication for transfer of equity shares to IEPF.
2 weeks agoPls find enclosed newspaper publication for transfer of equity shares to IEPF.
2 weeks agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 27 2026 for Aayush Agrawal trustee Aayush Agrawal Trust
3 weeks agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 27 2026 for Aayush Agrawal trustee Aayush Agrawal Trust
3 weeks agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 19 2026 for Ravi Agrawal trustee Ravi Agrawal Trust
1 month agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 19 2026 for Ravi Agrawal trustee Ravi Agrawal Trust
1 month agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 14 2026 for Ravi Agrawal trustee Ravi Agrawal Trust
1 month agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 14 2026 for Ravi Agrawal trustee Ravi Agrawal Trust
1 month agoPls find enclosed Intimation w.r.t participation in Investor Conference
1 month agoPls find enclosed Intimation w.r.t participation in Investor Conference
1 month agoPls find enclosed herewith Earning Call Transcript
1 month agoPls find enclosed herewith Earning Call Transcript
1 month agoPls find enclosed newspaper publication of financial results for the quarter ended 30.06.2026.
1 month agoPls find enclosed newspaper publication of financial results for the quarter ended 30.06.2026.
1 month agoPls find enclosed Audio Recording of Earnings Call
1 month agoPls find enclosed Audio Recording of Earnings Call
1 month agoPls find enclosed ESOP Allotment
1 month agoPls find enclosed ESOP Allotment
1 month agoPFA record date intimation
1 month agoPFA record date intimation
1 month agoPFA Dividend Intimation
1 month agoPFA Dividend Intimation
1 month agoResults of 30.06.2026.
1 month agoResults of 30.06.2026.
1 month agoBoard Meeting Outcome
1 month agoBoard Meeting Outcome
1 month agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 29 2026 for Aayush Agrawal trustee Aayush Agrawal Trust
1 month agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 29 2026 for Aayush Agrawal trustee Aayush Agrawal Trust
1 month agoPls find enclosed Revised Investor Call Intimation
2 months agoPls find enclosed Revised Investor Call Intimation
2 months agoPls fine enclosed Investor Call Intimation
2 months agoPls fine enclosed Investor Call Intimation
2 months agoAjanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 inter alia to consider and approve Update on board meeting
2 months agoAjanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 inter alia to consider and approve Update on board meeting
2 months agoAjanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 inter alia to consider and approve Financial Results for the quarter ended 30th June 2026.
2 months agoAjanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 inter alia to consider and approve Financial Results for the quarter ended 30th June 2026.
2 months agoPls find enclosed voting and scrutinizers report w.r.t to 47th AGM held on 16.07.2026.
2 months agoPls find enclosed voting and scrutinizers report w.r.t to 47th AGM held on 16.07.2026.
2 months agoPls find enclosed AGM Proceedings
2 months agoPls find enclosed AGM Proceedings
2 months agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 14 2026 for Ravi Agrawal trustee Ravi Agrawal Trust
2 months agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 14 2026 for Ravi Agrawal trustee Ravi Agrawal Trust
2 months agoThe Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 08 2026 for Aayush Agrawal trustee Aayush Agrawal Trust Aayush M Agrawal & Gabs Investments Pvt Ltd
2 months agoThe Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 08 2026 for Aayush Agrawal trustee Aayush Agrawal Trust Aayush M Agrawal & Gabs Investments Pvt Ltd
2 months agoPls find enclosed Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026.
2 months agoPls find enclosed Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026.
2 months agoConcalls & investor presentations
Jul 2026
May 2026
Jan 2026
Nov 2025
Jul 2025
ConcallPresentation
Apr 2025
Jan 2025
Oct 2024
Jul 2024
May 2024
Jan 2024
Oct 2023
Jul 2023
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
Nov 2022
Jul 2022
May 2022
Jan 2022
Oct 2021
Jul 2021
Apr 2021
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation